官方网站:http://www.tandfonline.com/toc/ierp20/current
投稿网址:https://mc.manuscriptcentral.com/erp
PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-7167%5BISSN%5D
《药物经济学与结果研究专家评论》(ISSN 1473-7167)提供有关药物临床使用和治疗方法的成本效益和药物经济学问题的专家评论。涵盖范围包括药物经济学和生活质量研究,治疗结果,循证医学和成本效益研究。所有的文章都要经过严格的同行评审。该杂志采用独特的专家评论文章格式,提供了一个关键技术领域、研究或临床实践的当前思想的完整概述,并辅以以下章节:专家评论-对最有效或最有前途的策略的个人观点五年展望——在一个现实的时间尺度内对未来前景的清晰展望关键问题-执行摘要削减到作者最关键的观点
Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategiesFive-year view - a clear perspective of future prospects within a realistic timescaleKey issues - an executive summary cutting to the author's most critical points
* 请认真填写需求信息,学术顾问24小时内与您取得联系。